BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11604021)

  • 41. 2D QSAR modeling and preliminary database searching for dopamine transporter inhibitors using genetic algorithm variable selection of Molconn Z descriptors.
    Hoffman BT; Kopajtic T; Katz JL; Newman AH
    J Med Chem; 2000 Nov; 43(22):4151-9. PubMed ID: 11063611
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic Algorithm guided Selection: variable selection and subset selection.
    Cho SJ; Hermsmeier MA
    J Chem Inf Comput Sci; 2002; 42(4):927-36. PubMed ID: 12132894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of a neural net-based QSAR algorithm (PCANN) with Hologram- and multiple linear regression-based QSAR approaches: application to 1,4-dihydropyridine-based calcium channel antagonists.
    Viswanadhan VN; Mueller GA; Basak SC; Weinstein JN
    J Chem Inf Comput Sci; 2001; 41(3):505-11. PubMed ID: 11410024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neural network studies. 2. Variable selection.
    Tetko IV; Villa AE; Livingstone DJ
    J Chem Inf Comput Sci; 1996; 36(4):794-803. PubMed ID: 8768768
    [TBL] [Abstract][Full Text] [Related]  

  • 45. QSAR study of heparanase inhibitors activity using artificial neural networks and Levenberg-Marquardt algorithm.
    Jalali-Heravi M; Asadollahi-Baboli M; Shahbazikhah P
    Eur J Med Chem; 2008 Mar; 43(3):548-56. PubMed ID: 17602800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Have artificial neural networks met expectations in drug discovery as implemented in QSAR framework?
    Dobchev D; Karelson M
    Expert Opin Drug Discov; 2016 Jul; 11(7):627-39. PubMed ID: 27149299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GA(M)E-QSAR: a novel, fully automatic genetic-algorithm-(meta)-ensembles approach for binary classification in ligand-based drug design.
    Pérez-Castillo Y; Lazar C; Taminau J; Froeyen M; Cabrera-Pérez MÁ; Nowé A
    J Chem Inf Model; 2012 Sep; 52(9):2366-86. PubMed ID: 22856471
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictive QSAR modeling of phosphodiesterase 4 inhibitors.
    Kovalishyn V; Tanchuk V; Charochkina L; Semenuta I; Prokopenko V
    J Mol Graph Model; 2012 Feb; 32():32-8. PubMed ID: 22023934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Advances in the replacement and enhanced replacement method in QSAR and QSPR theories.
    Mercader AG; Duchowicz PR; Fernández FM; Castro EA
    J Chem Inf Model; 2011 Jul; 51(7):1575-81. PubMed ID: 21644502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A group center overlap based approach for "3D QSAR" studies on TIBO derivatives.
    Sapre NS; Gupta S; Pancholi N; Sapre N
    J Comput Chem; 2009 Apr; 30(6):922-33. PubMed ID: 18785154
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evolutionary optimization, backpropagation, and data preparation issues in QSAR modeling of HIV inhibition by HEPT derivatives.
    Weekes D; Fogel GB
    Biosystems; 2003 Nov; 72(1-2):149-58. PubMed ID: 14642664
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Improving quantitative structure-activity relationship models using Artificial Neural Networks trained with dropout.
    Mendenhall J; Meiler J
    J Comput Aided Mol Des; 2016 Feb; 30(2):177-89. PubMed ID: 26830599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using particle swarms for the development of QSAR models based on K-nearest neighbor and kernel regression.
    Cedeño W; Agrafiotis DK
    J Comput Aided Mol Des; 2003; 17(2-4):255-63. PubMed ID: 13677491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of Deep and Shallow Neural Networks, the Universal Approximation Theorem, Activity Cliffs, and QSAR.
    Winkler DA; Le TC
    Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27783464
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variable selection and interpretation in structure-affinity correlation modeling of estrogen receptor binders.
    Marini F; Roncaglioni A; Novic M
    J Chem Inf Model; 2005; 45(6):1507-19. PubMed ID: 16309247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interpreting computational neural network QSAR models: a measure of descriptor importance.
    Guha R; Jurs PC
    J Chem Inf Model; 2005; 45(3):800-6. PubMed ID: 15921469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ensembles of Bayesian-regularized genetic neural networks for modeling of acetylcholinesterase inhibition by huprines.
    Fernández M; Caballero J
    Chem Biol Drug Des; 2006 Oct; 68(4):201-12. PubMed ID: 17105484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variable selection in nonlinear modeling based on RBF networks and evolutionary computation.
    Patrinos P; Alexandridis A; Ninos K; Sarimveis H
    Int J Neural Syst; 2010 Oct; 20(5):365-79. PubMed ID: 20945516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modified ant colony optimization algorithm for variable selection in QSAR modeling: QSAR studies of cyclooxygenase inhibitors.
    Shen Q; Jiang JH; Tao JC; Shen GL; Yu RQ
    J Chem Inf Model; 2005; 45(4):1024-9. PubMed ID: 16045297
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Application of BCUT metrics and genetic algorithm in binary QSAR analysis.
    Gao H
    J Chem Inf Comput Sci; 2001; 41(2):402-7. PubMed ID: 11277729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.